Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Highly expressed in cancer protein 1 (Hec1), a subunit of the Ndc80 complex, is crucial for kinetochore-microtubule attachment and chromosome segregation during mitosis. Overexpression of Hec1 is frequently observed in various cancers and contributes to chromosomal instability, making it a promising target for anticancer therapy.
Disruption of microtubule-Hec1 interaction, leading to chromosome segregation defects, mitotic arrest, and cell death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Highly expressed in cancer 1 (HEC1).